prikaz prve stranice dokumenta National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
  Preuzmi
PDF 145.87 KB
Znanstveni rad - Izvorni znanstveni rad
National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
HIV Medicine, 23 (2022), 5; 546-552. https://doi.org/10.1111/hiv.13194
Jilich, David; Skrzat‐Klapaczyńska, Agata; Fleischhans, Lukas; Bursa, Dominik; Antoniak, Sergii; Balayan, Tatevik; Begovac, Josip; Cicic, Alma; Dragovic, Gordana; Goekengin, Deniz; Harxhi, Arjan; Kase, Kerstin; Lakatos, Botond; Matulionyte, Raimonda; Mulabdic, Velida; Oprea, Cristiana; Papadopoulos, Antonios; Rukhadze, Nino; Tomazic, Janez; Tovba, Lida; Soják, Ľubomír; Vassilenko, Anne; Yancheva, Nina; Yurin, Oleg; Kowalska, Justyna Više autora...

Citirajte ovaj rad

Jilich, D., Skrzat‐Klapaczyńska, A., Fleischhans, L., Bursa, D., Antoniak, S., Balayan, T. ... Kowalska, J. (2022). National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region. HIV Medicine, 23. (5), 546-552. doi: 10.1111/hiv.13194

Jilich, David, et al. "National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region." HIV Medicine, vol. 23, br. 5, 2022, str. 546-552. https://doi.org/10.1111/hiv.13194

Jilich, David, Agata Skrzat‐Klapaczyńska, Lukas Fleischhans, Dominik Bursa, Sergii Antoniak, Tatevik Balayan, Josip Begovac, et al. "National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region." HIV Medicine 23, br. 5 (2022): 546-552. https://doi.org/10.1111/hiv.13194

Jilich, D., et al. (2022) 'National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region', HIV Medicine, 23(5), str. 546-552. doi: 10.1111/hiv.13194

Jilich D, Skrzat‐Klapaczyńska A, Fleischhans L, Bursa D, Antoniak S, Balayan T, i sur.. National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region. HIV Medicine [Internet]. 05.2022. [pristupljeno 12.04.2024.];23(5):546-552. doi: 10.1111/hiv.13194

D. Jilich, et al., "National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region", HIV Medicine, vol. 23, br. 5, str. 546-552, Svibanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:060139. [Citirano: 12.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:060139
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
AutorDavid Jilich
AutorAgata Skrzat‐Klapaczyńska
AutorLukas Fleischhans
AutorDominik Bursa
AutorSergii Antoniak
AutorTatevik Balayan
AutorJosip Begovac
AutorAlma Cicic
AutorGordana Dragovic
AutorDeniz Goekengin
AutorArjan Harxhi
AutorKerstin Kase
AutorBotond Lakatos
AutorRaimonda Matulionyte
AutorVelida Mulabdic
AutorCristiana Oprea
AutorAntonios Papadopoulos
AutorNino Rukhadze
AutorJanez Tomazic
AutorLida Tovba
AutorĽubomír Soják
AutorAnne Vassilenko
AutorNina Yancheva
AutorOleg Yurin
AutorJustyna Kowalska
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INFEKTOLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Infektologija
Sažetak (engleski)
Introduction: People living with HIV (PLWH) are at higher risk of poorer COVID-19 outcomes. Vaccination is a safe and effective method of prevention against many infectious diseases, including COVID-19. Here we investigate the strategies for national COVID-19 vaccination programmes across central and eastern Europe and the inclusion of PLWH in vaccination programmes. ----- Methods: The Euroguidelines in Central and Eastern Europe Network Group consists of experts in the field of infectious diseases from 24 countries in the region. Between 1 November 2020 and 19 March 2021 the group proceeded an on-line survey consisting of 20 questions. ----- Results: Twenty-two countries (out of 24 invited) participated in the survey and 20/22 countries in the period between December 2020 and March 2021 had already started their COVID-19 vaccination programme. In total, seven different vaccines were used by participating countries. In 17/21 countries (81%), vaccinated persons were centralized within the national registry. In 8/21 countries (38%) PLWH were prioritized for vaccination (the Czech Republic, Greece, Hungary, Lithuania, Montenegro, Romania, Slovakia, Slovenia) and the Czech Republic, Greece and Serbia had put in place national guidelines for vaccination of PLWH. In 14/20 countries (70%) vaccination was only provided by designated centres. Eighteen respondents (18/21; 85.7%) reported that they planned to follow up HIV patients vaccinated against COVID-19, mainly by measuring antibody levels and checking COVID-19 incidence (11/21; 52.3%). ----- Conclusions: This survey-based study suggests that there are significant differences in terms of prioritizing PLWH, the types of vaccines used, vaccination coverage, and the development and implementation of a vaccination programmes within the region. Regardless of heterogenicity and existing barriers within the region, systematic vaccination in PLWH should have the highest priority, especially in those with severe immunodeficiency, risk factors, and in the elderly, aiming for prompt and high vaccination coverage.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaHIV Medicine
Brojčani podacivol. 23, br. 5, str. 546-552
p-ISSN1464-2662
e-ISSN1468-1293
DOIhttps://doi.org/10.1111/hiv.13194
URN:NBNurn:nbn:hr:105:060139
Datum objave publikacije2022-05
URL dokumentahttps://onlinelibrary.wiley.com/doi/10.1111/hiv.13194
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-06-28 07:44:29